| Style | Citing Format |
|---|---|
| MLA | Rafizadeh S M, et al.. "Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications." Therapeutic Advances in Ophthalmology, vol. 18, no. , 2026, pp. -. |
| APA | Rafizadeh S M, Eroglu E, Haydar A A, Zeidabadinejad H, Heidari M, Rajabi M T, Aghajani A, Davarpanah A, Rezaei K, Soleimani M (2026). Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications. Therapeutic Advances in Ophthalmology, 18(), -. |
| Chicago | Rafizadeh S M, Eroglu E, Haydar A A, Zeidabadinejad H, Heidari M, Rajabi M T, Aghajani A, Davarpanah A, Rezaei K, Soleimani M. "Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications." Therapeutic Advances in Ophthalmology 18, no. (2026): -. |
| Harvard | Rafizadeh S M et al. (2026) 'Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications', Therapeutic Advances in Ophthalmology, 18(), pp. -. |
| Vancouver | Rafizadeh S M, Eroglu E, Haydar A A, Zeidabadinejad H, Heidari M, Rajabi M T, et al.. Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications. Therapeutic Advances in Ophthalmology. 2026;18():-. |
| BibTex | @article{ author = {Rafizadeh S M and Eroglu E and Haydar A A and Zeidabadinejad H and Heidari M and Rajabi M T and Aghajani A and Davarpanah A and Rezaei K and Soleimani M}, title = {Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications}, journal = {Therapeutic Advances in Ophthalmology}, volume = {18}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Rafizadeh S M AU - Eroglu E AU - Haydar A A AU - Zeidabadinejad H AU - Heidari M AU - Rajabi M T AU - Aghajani A AU - Davarpanah A AU - Rezaei K AU - Soleimani M TI - Dry Eye Disease in Thyroid Eye Disease: A Narrative Review of Pathogenic Mechanisms and Therapeutic Implications JO - Therapeutic Advances in Ophthalmology VL - 18 IS - SP - EP - PY - 2026 ER - |